Accendra Health Inc (ACH) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Accendra Health Inc stock (ACH) is currently trading at $2.07. Accendra Health Inc PS ratio (Price-to-Sales) is 0.05. Analyst consensus price target for ACH is $3.25. WallStSmart rates ACH as Underperform.
- ACH PE ratio analysis and historical PE chart
- ACH PS ratio (Price-to-Sales) history and trend
- ACH intrinsic value — DCF, Graham Number, EPV models
- ACH stock price prediction 2025 2026 2027 2028 2029 2030
- ACH fair value vs current price
- ACH insider transactions and insider buying
- Is ACH undervalued or overvalued?
- Accendra Health Inc financial analysis — revenue, earnings, cash flow
- ACH Piotroski F-Score and Altman Z-Score
- ACH analyst price target and Smart Rating
Accendra Health Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Accendra Health Inc (ACH) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, price/sales, price/book. Concerns around market cap and return on equity. Mixed signals suggest waiting for clearer direction before acting.
Accendra Health Inc (ACH) Key Strengths (4)
Growing significantly faster than its price suggests
Paying less than $1 for every $1 of annual revenue
94.51% of shares held by major funds and institutions
Trading at 1.44x book value, attractively priced
Supporting Valuation Data
Accendra Health Inc (ACH) Areas to Watch (5)
Company is destroying shareholder value
Revenue declining -73.70%, a shrinking business
Company is losing money with a negative profit margin
Near-zero operating margins, business under pressure
Micro-cap company with very limited liquidity and high volatility
Accendra Health Inc (ACH) Detailed Analysis Report
Overall Assessment
This company scores 43/100 in our Smart Analysis, earning a D grade. Out of 9 metrics analyzed, 4 register as strengths (avg 9.5/10) while 5 fall into concern territory (avg 0.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on PEG Ratio, Price/Sales, Institutional Own.. Valuation metrics including PEG Ratio (0.70), Price/Sales (0.05), Price/Book (1.44) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Revenue Growth, Profit Margin. Growth concerns include Revenue Growth at -73.70%, which may limit upside. Profitability pressure is visible in Return on Equity at -163.80%, Operating Margin at 2.94%, Profit Margin at -39.90%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -163.80% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -73.70% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Revenue Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
ACH Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
ACH's Price-to-Sales ratio of 0.05x trades at a deep discount to its historical average of 0.31x (1th percentile). The current valuation is 91% below its historical high of 0.59x set in Dec 2007, and 8% above its historical low of 0.05x in Dec 2018. Over the past 12 months, the PS ratio has compressed from ~0.1x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Accendra Health Inc (ACH) · HEALTHCARE › MEDICAL DISTRIBUTION
The Big Picture
Accendra Health Inc is in a turnaround phase, with management focused on restoring profitability. Revenue reached 2.8B with 74% decline year-over-year. The company is currently unprofitable, posting a -39.9% profit margin.
Key Findings
Generating 55M in free cash flow and 68M in operating cash flow. Earnings are translating into actual cash generation.
Revenue contracted 74% YoY. Worth determining whether this is cyclical or structural.
The company is unprofitable with a -39.9% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Sector dynamics: monitor MEDICAL DISTRIBUTION industry trends, competitive moves, and regulatory changes that could impact Accendra Health Inc.
Bottom Line
Accendra Health Inc is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 11:29:05 AM
About Accendra Health Inc(ACH)
NYSE
HEALTHCARE
MEDICAL DISTRIBUTION
USA
Aluminum Corporation of China Limited, manufactures and sells alumina, primary aluminum and energy products in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.